|
TECHNOLOGY READY TO MEASURE FOLLOW-ON BIOLOGICS, FIRM SAYS
Because of recent scientific advances, drugmakers are now able to reproduce follow-on biopharmaceutical products with the same measurable proprieties as those of the innovator firm, according to brand firm Novartis. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives